Emulate, Inc., secured $36 million in Series C financing led by Founders Fund, as well as new investors ALS Investment Fund, SciFi VC, members of GlassWall Syndicate Association, and existing investors. Emulate’s automated, lab-ready Human Emulation System is comprised of Organ-Chips, instrumentation, and software applications.
Juvenescence Limited, a life science and biotech company developing therapies to increase healthy human longevity, raised $50 million in its Series A financing. Founded in 2016 by Jim Mellon, Dr Greg Bailey, Dr Declan Doogan, Anthony Chow, and Alexander Pickett, the company creates, partners with,
Bigfinite, a biotech and pharma software provider, completed $8.5 million in seed financing, led by Crosslink Capital, Uncork Capital, and La Famiglia. Industry Ventures and Krohne also participated in the funding. The company’s SaaS platform acquires, visualizes, and records regulated data from biotech and pharma
According to a recent SEC filing, Phytonix has raised $979,824 in financing from an undisclosed investor. Phytonix Corporation is an industrial biotechnology company producing sustainable chemicals directly from carbon dioxide. The company’s patented process employs cyanobacteria, and it is a professional in bio-safe, direct solar chemicals
Front Range Biosciences announced the completion of $3 million in financing. Eight investors participated in the round: Phyto Partners, Salveo Capital, Sand Hill Angels, New York Angels, HBS Angels of NYC, HALLEY Venture Partners, Anthill Ventures, and Canopy Boulder. Front Range Biosciences is a vertically integrated